Elevated expression of BRD4 in pancreatic cancer has been attributed to presence of 5-hydroxymethylcytosine (5hmC) at the BRD4 promoter, indicative of an active DNA demethylation process (ADD) [39]. Here, BRD4 is linked to pancreatic neoplasm.